MediXall Group, Inc.

CIK 1601280 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MediXall Group, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026NT 10-Q0001079973-26-001106
May 15, 2026NT 10-Q0001079973-26-000668
Mar 31, 2026NT 10-K0001079973-26-000384
Nov 14, 2025NT 10-Q0001079973-25-001733
Sep 8, 202510-Q0001079973-25-001435
Aug 14, 2025NT 10-Q0001079973-25-001276
Jun 5, 202510-Q0001079973-25-000991
May 19, 202510-Q0001079973-25-000902
May 15, 2025NT 10-Q0001079973-25-000804
Apr 23, 20258-K0001553350-25-000008
Apr 1, 2025NT 10-K0001079973-25-000570
Jan 27, 202510-K0001079973-25-000141
Nov 14, 2024NT 10-Q0001079973-24-001522
Aug 15, 2024NT 10-Q0001079973-24-001254
Jun 20, 202410-Q0001079973-24-000912
Jun 6, 202410-Q0001079973-24-000835
May 14, 202410-Q0001079973-24-000706
Apr 1, 2024NT 10-K0001079973-24-000464
Feb 12, 2024SEC STAFF ACTION9999999997-24-000271
Dec 12, 20238-K0001079973-23-001735
Dec 12, 20238-K0001079973-23-001733
Nov 14, 2023NT 10-Q0001079973-23-001568
Oct 11, 20238-K0001079973-23-001414
Aug 14, 2023NT 10-Q0001079973-23-001155
Aug 9, 202310-K0001079973-23-001099